000 01285 a2200373 4500
005 20250512201256.0
264 0 _c19820527
008 198205s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(82)91776-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPasi, A
245 0 0 _aFailure of naloxone to reverse analgesia in congenital insensitivity to pain, and variable plasma levels of beta-endorphin-like activity.
_h[electronic resource]
260 _bLancet (London, England)
_cMar 1982
300 _a622 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aClinical Trials as Topic
650 0 4 _aDouble-Blind Method
650 0 4 _aEndorphins
_xphysiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNaloxone
_xtherapeutic use
650 0 4 _aPain Insensitivity, Congenital
_xdrug therapy
650 0 4 _aRandom Allocation
700 1 _aMeyer, M
700 1 _aBoltshauser, E
700 1 _aFoletta, D
700 1 _aGramsch, C
773 0 _tLancet (London, England)
_gvol. 1
_gno. 8272
_gp. 622
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(82)91776-7
_zAvailable from publisher's website
999 _c6174883
_d6174883